This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, Z. Articles by Carr, B. I. Search for Related Content PubMed PubMed Citation Articles by Wang, Z. Articles by Carr, B. I.

Involvement of Cdc25A Phosphatase in Hep3B Hepatoma Cell Growth Inhibition Induced by Novel K Vitamin Analogs¹

Departments of Surgery [Z. W., M. W., S. K., B. I. C.], Pharmacology [E. C. S., J. S. L.], and Chemistry [K. S. R., C. S. W.], Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, Pennsylvania 15261

We previously found that K vitamin analogues caused cell growth inhibition in Hep3B hepatoma cells in vitro, which was associated with their inhibitory effects on protein tyrosine-phosphatases. In this study, we show that Cdc25A, a protein phosphatase, was inactivated by novel arylating K vitamin analogues. The inactivation of Cdc25A correlated with their effects on cell growth inhibition. Cyclin-dependent kinase (Cdk) 4, an important regulator for G₁ progression, was found to be tyrosine-phosphorylated by the arylating analogues, and this phosphorylation was correlated with the inhibitory effects of the analogues on Cdc25A activity. Furthermore, Cdk4 dephosphorylation experiments showed that Compound (Cpd) 5, a prototype arylating analogue, inhibited Cdc25A-mediated Cdk4 dephosphorylation, whereas Cpd 26, a nonarylating vitamin K analogue, had no effect on this event. We also examined Cdk4 kinase activity using retinoblastoma protein as a substrate and found that Cpd 5 inhibited retinoblastoma protein phosphorylation in a concentration-dependent manner, indicating that Cdk4 activity was inhibited by Cpd 5 treatment. Moreover, the thiol-antioxidants glutathione and N-acetyl-L-cysteine antagonized the Cpd 5-induced Cdk4 tyrosine phosphorylation, whereas the nonthiol-antioxidants catalase and superoxide dismutase did not. These results suggest that Hep3B cell growth inhibition by these K vitamin analogues may be related in part to inactivation of Cdc25A activity and support the hypothesis that Cdc25A is an attractive target for drugs designed to inhibit cancer cell growth.

This article has been cited by other articles:

				S. Kar, M. Wang, K. S. Rosi, C. S. Wilcox, and B. I. Carr Inhibition of rat liver regeneration after partial hepatectomy and induction of ERK phosphorylation by Cpd 5, a K vitamin-based anticancer compound Carcinogenesis, December 1, 2004; 25(12): 2345 - 2351. [Abstract] [Full Text] [PDF]

				Y. Han, H. Shen, B. I. Carr, P. Wipf, J. S. Lazo, and S.-s. Pan NAD(P)H:Quinone Oxidoreductase-1-Dependent and -Independent Cytotoxicity of Potent Quinone Cdc25 Phosphatase Inhibitors J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 64 - 70. [Abstract] [Full Text]

				X. Xu, H. Yamamoto, M. Sakon, M. Yasui, C. Y. Ngan, H. Fukunaga, T. Morita, M. Ogawa, H. Nagano, S. Nakamori, et al. Overexpression of CDC25A Phosphatase Is Associated with Hypergrowth Activity and Poor Prognosis of Human Hepatocellular Carcinomas Clin. Cancer Res., May 1, 2003; 9(5): 1764 - 1772. [Abstract] [Full Text] [PDF]

				S. Kar, M. Wang, C. S. Wilcox, and B. I. Carr Antitumor and anticarcinogenic actions of Cpd 5: a new class of protein phosphatase inhibitor Carcinogenesis, March 1, 2003; 24(3): 411 - 416. [Abstract] [Full Text] [PDF]

				L.-O. Klotz, P. Patak, N. Ale-Agha, D. P. Buchczyk, K. Abdelmohsen, P. A. Gerber, C. von Montfort, and H. Sies 2-Methyl-1,4-naphthoquinone, Vitamin K3, Decreases Gap-Junctional Intercellular Communication via Activation of the Epidermal Growth Factor Receptor/Extracellular Signal-regulated Kinase Cascade Cancer Res., September 1, 2002; 62(17): 4922 - 4928. [Abstract] [Full Text] [PDF]

				Z. Wang, M. Wang, J. S. Lazo, and B. I. Carr Identification of Epidermal Growth Factor Receptor as a Target of Cdc25A Protein Phosphatase J. Biol. Chem., May 24, 2002; 277(22): 19470 - 19475. [Abstract] [Full Text] [PDF]